<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4052188&amp;fmt=gif">

As the only e-signature vendor exhibiting during the Global Site Solutions Summit, SIGNiX had the unique opportunity to collect every detail of the needs of clinical investigative sites. Global Site Solutions Summit, a conference to advance the ethical and efficient conduct of clinical research and to encourage and build strong site partnerships, was held in Amelia Island, Florida October 8-11.

SIGNiX contributed to the conference as an IMPACT Sponsor, to demonstrate our IMPACT Sponsors at Global Site Solutions Summitcommitment to the productivity of clinical research. During our time at the conference, Business Development Executive, Hamilton Temple, had the opportunity to take the spotlight to talk about how perfectly SIGNiX’s Independent E-Signature™ solution compliments life sciences.

Hamilton reported that clinical investigators confirmed how well e-signatures fit in to the life sciences industry, many of them are still drowning in stacks of paper. Hamilton said, “The first instance investigators would mention is the Form 1572 signing process.” Form 1572, which states that “No investigator may participate in an investigation until he/she provides the sponsor with a completed, signed Statement of Investigator, Form FDA 1572 (21 CFR312.53 (c)),”has to be signed by anyone and everyone who is involved with a clinical trial. This process that used to take several days, possibly months, can be over in just a few hours, as long as everyone has Internet access.

Independent E-Signatures™, in particular, are the ideal fit for companies in the life sciences and clinical research space because these digital certificate-based signatures meet key industry regulations, like 21 CFR Part 11, and provide the highest level of security and data encryption.

SIGNiX has proven its e-signature success with clinical research organizations. Last year, the Independent E-signature™ provider partnered with a top clinical research organization to reduce the time required to sign clinical trial documents.

To read how SIGNiX was able to reduce physicians’ signing time by 94 percent while saving approximately $250,000 in paper-related costs, download this free case study.

Download Now!

You may also like

SIGNiX Announces IMPACT Sponsorship of Global Site Solutions Summit
SIGNiX Announces IMPACT Sponsorship of Global Site Solutions Summit
5 October, 2015

SIGNiX will participate as an IMPACT sponsorship for the Global Site Solutions Summit, an event dedicated to helping cli...

SIGNiX Takes E-Signatures to Disruptive Innovations 2015
4 September, 2015

SIGNiX is excited to be a part of a conference that is bringing innovations to the Life Sciences community. This year, w...

SIGNiX Independent E-Signatures™ Featured in Applied Clinical Trials 
9 September, 2015

The need for speed in clinical trials is astounding. A report by Ronald D. Snee of Tunnell Consulting found each day a b...